Development, Strategies, and Challenges for Tularemia Vaccine.
Curr Microbiol
; 81(5): 126, 2024 Apr 02.
Article
en En
| MEDLINE
| ID: mdl-38564047
ABSTRACT
Francisella tularensis is a facultative intracellular bacterial pathogen that affects both humans and animals. It was developed into a biological warfare weapon as a result. In this article, the current status of tularemia vaccine development is presented. A live-attenuated vaccine that was designed over 50 years ago using the less virulent F. tularensis subspecies holarctica is the only prophylactic currently available, but it has not been approved for use in humans or animals. Other promising live, killed, and subunit vaccine candidates have recently been developed and tested in animal models. This study will investigate some possible vaccines and the challenges they face during development.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Tularemia
/
Vacunas
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Curr Microbiol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Irán